Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update
David Wojciechowski, Flavio VincentiKidney Transplant Service, University of California, San Francisco, CA, USAAbstract: In June 2011, the US Food and Drug Administration approved belatacept for the prophylaxis of organ rejection in adult kidney transplant recipients. This review discusses the use o...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-11-01
|
| Series: | Biologics : Targets & Therapy |
| Online Access: | http://www.dovepress.com/belatacept-for-prevention-of-acute-rejection-in-adult-patients-who-hav-a11420 |